Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
Washington University in St. Louis · University of Minnesota Medical Center · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
107
total citations
- FWCI
- 83.24
- Percentile
- 100%
- References
- 34
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Rituximab
- Regimen
- Cytokine release syndrome
- Fludarabine
- Chimeric antigen receptor
- Tolerability
- Pharmacology
No related works found for this paper.